For U.S. Healthcare Professionals Only

About
Varicella-Zoster

Understanding Varicella

Varicella (chickenpox) is an acute infectious disease caused by the varicella zoster virus (VZV), a DNA virus belonging to the herpesvirus group. Following primary infection, VZV establishes latency within the sensory nerve ganglia. Primary infection with VZV results in Chickenpox, while reactivation of latent infection leads to the development of shingles.1

Although the use of the varicella vaccine has reduced the frequency of chickenpox, the virus has not been eradicated. Chickenpox outbreaks continue to occur even in settings such as schools where most children are vaccinated. 2, 3

This is particularly relevant for high-risk patients who are more susceptible to severe disease and complications.4

Symptoms

Individuals who have not contracted varicella, lack evidence of immunity, nor received the varicella vaccine, are susceptible to the disease.

A chickenpox rash typically lasts 4 to 7 days and is characterized by itchy, fluid-filled blisters that eventually crust over.
The rash initially manifests on the chest, back, and face before spreading throughout the body to include surfaces like the mouth, eyelids and genital area.

The onset of other common symptoms, such as fever, fatigue, decreased appetite, and headache, may precede the rash by one to two days.5

Definition of Exposure 6, 7

Close contact with an infectious person may include close indoor contact (e.g., in the same room) or face-to-face contact. Experts differ in their opinion about the duration of contact; some suggest 5 minutes and others up to 1 hour.

Varicella zoster virus exposure that may result in infections includes:

Exposure to Chickenpox patients
that are likely to result in infection include:

  • Household exposure: infected contact residing in the same household
  • Face-to-face indoor play of 5 minutes or more (some experts suggest >1 hour as the threshold for significant exposure through direct contact)
  • Hospital exposure

Exposure to Shingles patients
that are likely to result in infection include:

  • Close contact, such as touching or hugging
  • Transmission has been seen to occur even when an HZ
rash is covered

Facts

In the US, the incidence of VZV infection has decreased dramatically since the introduction of the varicella vaccine in 1995; however, suboptimal vaccination rates contribute to outbreaks and an increased risk of VZV exposure.8, 9, 10

As of 2023, the national Varicella Vaccine coverage for children by age 24 months was approximately 91%10

Increasing rates of under-vaccination and vaccine hesitancy in recent years are associated with vaccine-preventable disease outbreaks1

Vaccination disparities exist between foreign-born and US-born population12

Outbreaks of vaccine-preventable diseases are more likely to occur in areas where nonimmunized patients are clustered13

Varicella Zoster
Exposure Complications

High-risk individuals exposed to VZV can result in severe or complicated varicella, including pneumonitis, encephalitis, and hepatitis. Non-immune adults,
immunocompromised patients, and preterm infants are at highest risk of developing severe or complicated varicella. 14

Immunocompromised patients without evidence of immunity to Varicella

Varicella is likely to be severe in patients whose immunity is compromised, either due to a congenital immunodeficiency, transplantation, or various treatments for malignant or autoimmune disease. These patients are particularly prone to develop pneumonia and hepatitis due to VZV, which may be fatal.15

Preganant women without evidence of immunity to Varicella

Pregnant individuals who contract varicella (chickenpox) face a heightened risk of serious complications, most notably pneumonia, which can be severe and occasionally fatal. Some research indicates that both the occurrence and severity of varicella-related pneumonia are greater when the infection is acquired in the third trimester; however, this finding is not consistently supported across all studies.16

Infants without evidence of immunity to Varicella

Children born to pregnant women who develop varicella are at risk of sequelae from congenital varicella syndrome, depending on the timing of exposure during pregnancy. Newborn infants whose mothers develop varicella within 5 days before delivery or within 48 hours after delivery are at particularly high risk of severe varicella, likely due to the absence of protective transplacental VZV antibodies before birth.14

References: [1] CDC: Clinical Overview of Chickenpox (Varicella) [2] CDC: Varicella Outbreak Identification, Investigation, & Control [3] CDC: Chickenpox Vaccination [4] Varicella / Chickenpox CDC Yellow Book 2024 [5] CDC: Chickenpox Symptoms and Complications [6] Pergam SA, Limaye AP; AST Infectious Diseases Community of Practice. Varicella-zoster virus (VZV) in solid organ transplant recipients. Am J Transplant. 2009 Dec;9 Suppl 4(Suppl 4):S108-15. doi: 10.1111/ j.1600-6143.2009.02901.x. PMID: 20070670; PMCID: PMC2919834. [7] Kendra Viner, Dana Perella, Adriana Lopez, Stephanie Bialek, Claire Newbern, Rodrerica Pierre, Niya Spells, Barbara Watson, Transmission of Varicella Zoster Virus From Individuals With Herpes Zoster or Varicella in School and Day Care Settings, The Journal of Infectious Diseases, Volume 205, Issue 9, 1 May 2012, Pages 1336–1341, https://doi.org/10.1093/infdis/jis207 [8] Bialek SR, Perella D, Zhang J, Mascola L, Viner K, Jackson C, et al. Impact of a routine two-dose varicella vaccination program on varicella epidemiology. Pediatrics. 2013;132(5):e1134-e1140. [9] Anne M. Lachiewicz, Megan L. Srinivas, Varicella-zoster virus post-exposure management and prophylaxis: A review, Preventive Medicine Reports, Volume 16,2019,101016,ISSN 2211-3355. [10] Vaccination Coverage by Age 24 Months Among Children Born in 2019 and 2020 — National Immunization Survey-Child, United States, 2020–2022 [11] Zerbo U, Modaressi S, Goddard K, et al. Vaccination patterns in children after autism spectrum disorder diagnosis and in their younger siblings. JAMA Pediatr. 2018;172(5):469-475. [12] Healy J, Rodriguez-Lainz A, Elam-Evans LD, Hill HA, Reagan-Steiner S, Yankey D. Vaccination coverage among foreign-born and U.S.-born adolescents in the United States: Successes and gaps – National Immunization Survey-Teen, 2012-2014. Vaccine. 2018 Mar 20;36(13):1743-1750. doi: 10.1016/j.vaccine.2018.02.052. Epub 2018 Feb 23. PMID: 29483032; PMCID: PMC6251305. [13] Buttenheim AM, Cherng ST, Asch DA. Provider dismissal policies and clustering of vaccine-hesitant families: an agent-based modeling approach. Hum Vaccin Immunother. 2013 Aug;9(8):1819-24. doi: 10.4161/hv.25635. Epub 2013 Jul 5. PMID: 23831786; PMCID: PMC3906288. [14] Levin MJ, Duchon JM, Swamy GK, Gershon AA (2019): Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program. PLoS ONE 14(7): e0217749. [15] Gershon AA. Is chickenpox so bad, what do we know about immunity to varicella-zoster virus, and what does it tell us about the future? J Infect. 2017 Jun;74 Suppl 1(Suppl 1):S27-S33. doi: 10.1016/S0163-4453(17)30188-3. PMID: 28646959; PMCID: PMC5726865. [16] CDC Clinical Guidance for People at Risk for Severe Varicella.